The Feasibility of Using Metacognitive Strategy Training to Improve Cognitive Performance and Neural Connectivity in Women with Chemotherapy-Induced Cognitive Impairment.

The Feasibility of Using Metacognitive Strategy Training to Improve Cognitive Performance and Neural Connectivity in Women with Chemotherapy-Induced Cognitive Impairment.
复制标题

使用元认知策略训练来改善化疗引起的认知障碍女性的认知表现和神经连接的可行性。

DOI:
10.1159/000447744
复制
发表时间:
2016
期刊:
影响因子:
3.5
通讯作者:
Piccirillo,Jay
Piccirillo,Jay
中科院分区:
医学3区
文献类型:
--
作者:
Wolf,TimothyJ;Doherty,Meghan;Kallogjeri,Dorina;Coalson,RebeccaS;Nicklaus,Joyce;Ma,CynthiaX;Schlaggar,BradleyL;Piccirillo,Jay

文献摘要

相似文献

Objective:To evaluate the feasibility and preliminary effect of metacognitive strategy training (MCST) on cognitive performance and on neural connectivity in the frontoparietal network in women with chemotherapy-induced cognitive impairment (CICI) following treatment for breast cancer.Methods:A single-group pre/post study was conducted. After completing the baseline assessment battery and neuroimaging, the participants completed a 12-session MCST intervention. Following the completion of the intervention, the subjects completed the same assessment battery and neuroimaging as was completed at baseline within 4 weeks after the intervention. The key inclusion/exclusion criteria for this study were: completed chemotherapy for treatment of breast cancer, no other neurological or psychiatric diagnoses, self-reported CICI, and no contraindications to the use of MRI.Results:MCST had a small-to-large positive effect on all primary (cognitive) and secondary (quality of life and psychosocial) behavioral outcome measures (r = -0.12 to -0.88). There was also a positive change in functional connectivity in a frontoparietal cognitive control network connection in 6 of the 10 subjects, which was correlated to changes in the behavioral measures.Conclusions:This study found that MCST was associated with a positive effect on cognitive performance and neural connectivity in women with CICI following treatment for breast cancer.